BCL2 and non-small cell lung carcinoma: On the other hand, knockdown of ARID1A upregulates the expression of cycle-related proteins cyclinD1 and Bcl-2 and inhibits cell apoptosis in non-small cell lung cancer (NSCLC) (87).